Medicode
ActiveThe computed 12-month bankruptcy probability of Medicode is 2.1% (moderate). The 2025 annual accounts show equity of €36k and a net result of €-14k. Its solvency ranks better than 62% of 11297 sector peers (fiscal year 2025). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
45
/ 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes
Profitability0
Solvency82
Growth-
Track record67
Bankruptcy probability, 12 months
2.1%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €1.5k at 30 days acceptable
Liquidity ample (current ratio 2.34; short-term debt: 42.8% and cash: 3.2% of total assets), and 42.8% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
57.2%
Return on assets
-21.6%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-07-2026, 25 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
25 d early
← before the deadline
after the deadline →
Financials · fiscal year 2025, micro schema
Equity
€36k
Total assets
€63k
Net result
€-14k
Working capital
€36k
Turnover and EBIT margin not published: the micro schema does not require them.
Balance-sheet composition
Equity and liabilities €63k
Equity
€36k
Debt
€27k
Debt finances 42.8% of the balance-sheet total.
Key figures and ratios
Solvency
57.2%
Current ratio
2.34
Quick ratio
0.13
Debt / equity
0.75
ROE
-37.8%
ROA
-21.6%
Debt
€27k
Debt ≤ 1 year
€27k
Filed annual accounts
As filed with the NBB · 2025
Balance sheet
Code2025
Assets
Total assets20/58€63k
Current assets29/58€63k
Stocks and contracts in progress3€60k
Stocks30/36€60k
Amounts receivable within one year40/41€1k
Other amounts receivable41€1k
Cash at bank and in hand54/58€2k
Equity and liabilities
Total equity and liabilities10/49€63k
Equity10/15€36k
Contributions10/11€50k
Profit (loss) carried forward14€-14k
Amounts payable17/49€27k
Amounts payable within one year42/48€27k
Trade debts44€3k
Suppliers440/4€3k
Other amounts payable47/48€25k
Income statement
Code2025
Other operating charges640/8€4k
Gross operating margin9900€-8k
Operating profit (loss)9901€-13k
Financial income75/76B€72
Recurring financial income75€72
Financial charges65/66B€1k
Recurring financial charges65€1k
Profit (loss) for the period before taxes9903€-14k
Profit (loss) for the period9904€-14k
Profit (loss) for the period to be appropriated9905€-14k
Appropriation of the result
Profit (loss) to be appropriated9906€-14k
The notes to these accounts (1 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2026
06-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
NBB filing
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 2024
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Herentalsebaan 1412150 AntwerpenGround area
438 m²
Building footprint
124 m²
Volume, LiDAR
1,053 m³
Parcel 11007A0002/00H004, Flanders · tallest building 10.2 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Medicode
since 20242.363.350.659
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11007A0002/00H004 | Flanders | 438 m² | 1 · 124 m² | 10.2 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Global Care
BE 0747.543.861
Brasschaat · Eq €36k
FIRSTAID4ALL
BE 0733.997.416
Lommel · Eq €36k
URSERVICES
BE 0712.759.364
Sint-Jans-Molenbeek · Eq €36k
BELIPHARM
BE 0884.446.592
Leuven · Eq €36k
PALOMA CURIOSA
BE 0440.318.335
Roeselare · Eq €37k
Of 1,898 companies in sector 46460 we hold annual accounts for 1,116. 419 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded02-09-2024
Fiscal year end31-12
Activities, NACEBEL
46460Wholesale of pharmaceutical and medical goods
Sources
Crossroads Bank for EnterprisesNational Bank · 1 filingAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.